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Endogenous antioxidants and lipoprotein oxidation
Ht-RMANN ESTERBAUER. means that the lipid peroxidation process enters into the propagating phasc; ( 2 ) the propagation phase is characterized by a rapid oxidation of the PUFAS t o lipid-hydroperoxides. The increase of the lipid pcroxidcs can be measured by iodometric assays or. more conveniently. by the continuous recording o f the increase o f the U.V. absorption at 234 nm (Fig. 1 ) . which develops through the formation o f hydrogen peroxide with the conjugated douhlc bond system CH=CH-CH=CH-CH( 0OH)--; (3) the decomposition phase, in which the lipid peroxides decompose t o a great variety of products. A number of reactive aldehydes were identified, such as malonaldehyde, 4-hydroxynonenal, 4-hydroxyhexenal, 4-hydroxyoctenal, propanal, butanal. penatanal. hcxannl. octanal and 2.4-heptadienal. A numher o f findings suggest that these reactive aldehydes, which arc generated within the LDL paticle, react at or near the site o f The LDL samples 1 to 5 with increasing vitamin E content were prepared by supplementation of plasma with all-raca-tocopherol. To the LDL solution (0.25 mg/ml of PBS) was added 1.66 PM-CUSO, and the oxidation was continuously followed by recording the increase of the 234 nm diene absorption. The insert shows the dependence of the lag phase from the a-tocopherol content of the LDL prepared from two different plasma samples, line A is the plasma for which the five diene curves are shown.
HERBERT PUHL and F R A N Z TATZBER
their origin with neighbouring amino acid residues of apolipoprotein B, and thereby generate epitopes, which are ligands for the macrophage scavenger receptor. Polyclonal and monoclonal antibodies developed against malonaldehyde or hydroxynonenal modified LDL recognize oLDL 18-101. Moreover, immunocytochemical stainings with these antibodies indicate the presence of such aldehyde modified proteins in atherosclerotic lesions of rabbits.
We were interested in the factors which determine the length of the lag phase during which LDL is protected against oxidation and assumed that the amount of the endogenous antioxidants play a crucial role. On a molar base, by far the major antioxidant in LDL is a-tocopherol. The mean value of 2.59 nmol/mg of LDL (Table 1) corresponds to about six molecules per LDL particle (the molecular mass of LDL is 2.5 million). All other antioxidants are present in much lower concentrations. Altogether they represent only about one molecule/LDL particle. Thus, on average an LDL particle contains seven molecules of endogenous antioxidants, which have to protect about 1200 PUFA molecules. The antioxidant: PUFA ratio is 1 : 170.
In Cu'+ -initiated LDL oxidation, the antioxidants always disappeared in the sequence: a-tocopherol, y-tocopherol, carotenoids and oxycarotenoids; rapid LDL oxidation only occurred when the LDL was depleted from these antioxidants. Preliminary tissue culture experiments in our laboratory with endothelial cells from human umbilical vein and porcine aortae show similar results. This would suggest that the oxidation resistance (i.e. duration of lag phase) can be predicted from its antioxidant content. This, however, seems not to be the case. We have determined the antioxidants and the lag phase in a large number of LDL samples prepared from blood of clinically healthy volunteers and found that (a) the lag phases show an extremely high variation from 44 to 150 min (Table l) , (b) LDL with high antioxidant content were in general more resistant to oxidation, but there were also exceptions from this trend and (c) in the statistical evaluation of all data a-tocopherol is correlated with the lag phase only with r' = 0.36. In a related study Babiy et al. [ I l l found essentially no correlation between LDL a-tocopherol content and its oxidizability by y-irradiation. This weak statistical correlation does in our opinion not contradict the kinetic findings according to which the oxidation of LDL is always preceded by sequential loss of its antioxidants, but rather suggests that the oxidation resistance of a particular LDL depends on more than one (i.e. antioxidant content) variable. What this additional variable factor could be is presently unknown. Possible explanations could be pre-existing peroxides in the LDL, different PUFA content, additional unknown antioxidants, different binding sites for the pro-oxidative Cu2+ ions and others.
To further evaluate the potential role of a-tocopherol for the oxidation resistance of LDL, various supplementation studies were performed. First (for details see 11 21). the plasma of individual volunteers was supplemented with vitamin E (all-rac a-tocopherol) in concentrations of 125-1000 nmol/ ml and LDL was isolated after a preincubation period of 3 h at 37°C. About 1-3% of the added vitamin E was incorporated into the LDL and the vitamin E content could thus be increased to about 12 nmol/mg, which is about four times its basal level. The oxidation resistance of these vitamin E-enriched LDL samples always increased linearly with the vitamin E content. The correlation between lag phase and vitamin E/mg of LDL was in all cases highly significant with r2 = 0.95 or better. A typical example of the determination of the lag phase and the kinetic of the oxidation process of such vitamin E-supplemented LDL samples is shown in Fig. 1 . It should be noted here that the slope of the correlation line varied considerably from donor to donor, which suggests individual differences in the effectiveness of vitamin E. The insert in Fig. 1 shows two such lines determined with the plasma of two different donors. In one case, 1 nmol of vitamin E per mg of LDL prolonged the lag phase by 6.8 min, in the other by 12.8 min.
In addition to these experiments in vitro, we have also made an ex vivo study: volunteers (male, female, 20-30 years, clinically healthy) took daily RRR-a-tocopherol for three weeks. (150 IU, 225 IU, 800 IU, 1200 IU, 2 persons per dose, 4 persons placebo). The a-tocopherol content of LDL from the volunteers and its oxidation resistance was determined 2 days prior to the supplementation, in five intervals during the supplementation and 1 week after the supplementation. A typical protocol is shown in Table 2 . The major findings of this ex vivo study are: (a) the a-tocopherol of LDL and also its oxidation resistance significantly increased during the 3 weeks of supplementation; (b) the relative oxidation resistance (ROR) i.e. mean lag phase measured during the supplementation period relative t o the lag phase prior to supplementation was 1.17, 1.56, 1.35 and 1.75 for the dose of 150,225,800 and 1200 IU of vitamin E. The ROR of the placebo group was 0.93; (c) the given effectiveness of vitamin E to increase the oxidation resistance varied from person to person. For four persons. the lag phase Tocopherol (nmol/mg LDL)
o~~" " ' " " " " ' " ' " " ' ' ' " ' correlated with a-tocopherol highly significantly with r' = 0.74-0.89, for four persons this correlation was less ( r2 = 0.48-0.60) and for the other four persons no correlation existed ( $ = 0.06-0.28); ( d ) if all values for a-tocopherol and lag phase obtained in this study are treated statistically, the correlation coefficient of r2=0.51 is obtained (Fig. 2) ; and (e) inclusion of the other antioxidants ( y-tocopherol, carotenoids) in the statistics only marginally increases the correlation shown in Fig. 2 .
In conclusion, our data from the in vitro and ex vivo studies show that vitamin E is an important, but not the only parameter which determines the oxidation resistancc of LDL. Additional studies (e.g. supplementation with p- T h e oxidation of plasma lipoproteins, especially the lowdensity fraction. may be an important step in the development o f atherosclerosis [ I ] . Lipoproteins can be modified in vitro by the action of free radicals generated by cellular activity, leading to a loss of antioxidants in the low-density lipoproteins (LDL), oxidation of fatty acids and formation of lysolecithin and the modification of lysine residues on the apolipoprotein B [2. 31. This process can be mimicked by incubation with low concentrations of transition metal ions e.g. 5 ~M -C U ? + or iron ions. Even at the early stages of oxidation. cytotoxic products, probably lipid in origin, are released and may impair the function of the endothelium and other cell types.
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Etidothelium-derived relaxirig factor in atherosclerosis
T h e stimulation of the endothelium by various agents elicits the release of endothelium-derived relaxing factor ( E D R F ) [4] which has now been shown to be identical to the gas nitric oxide IS]. It is an important relaxant o f vascular muscle and will relax arteries which have been contracted by Abbreviations used: LIIL. low-density lipoproteins: 5-HT, 5-hydroxytrypamine. agents such as 5-hydroxytryptamine ( 5 -H T ) and noradrenaline. T h e free radical N O is synthesized from the amino acid arginine 161. There is a constant basal release from the endothelium under the stimulus of pulsatile flow. In experimental atherosclerosis [7] there is impairment of endothelium-dependent relaxation even when the endothelium is still in place. In coronary arteries of human subjects impairment of relaxation occurs in areas of endothelial dysfunction or atherosclerosis [8] and this could also be related t o increased plasma cholesterol concentrations [ 01. One explanation of this phenomenon may be the presence of oxidized LDL in the atherosclerotic plaque.
In organ bath studies on rabbit aortic rings, native LDL was shown to inhibit the relaxation of the precontracted rings, but the effects were immediate and reversible [ 101. Oxidized LDL, on the other hand, inhibited more potently, but required a lag period before the inhibition occurred. Furthermore the inhibition was often irreversible, depending on the extent of oxidation of the LDL sample used [ 101. This variability is itself interesting and is consistent for particular donors who give blood for LDL isolation. T h e individuals with LDL showing the greatest sensitivity to oxidation by C u 2 + cause the greatest and irreversible ihibition of relaxation. It has been suggested that lysolecithin may be the active cytotoxic agent [ 111, but it does not behave exactly the same as oxidized LDL and the amounts of this phospholipid in the different lipoprotein samples d o not correspond well t o thc inhibitory effects of the oxidized LDL preparations (F. Plane, K. R. Bruckdorfer & M. Jacobs, unpublished work). T h e effects of oxidized LDL are inhibited by high-density lipo-
